New Zealand markets open in 1 hour 39 minutes

Entrada Therapeutics, Inc. (TRDA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
14.49+0.30 (+2.11%)
At close: 04:00PM EDT
14.49 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 479.04M
Enterprise value 218.06M
Trailing P/E 20.57
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.93
Price/book (mrq)1.78
Enterprise value/revenue 1.34
Enterprise value/EBITDA 8.09

Trading information

Stock price history

Beta (5Y monthly) -0.39
52-week change 35.27%
S&P500 52-week change 326.16%
52-week high 318.44
52-week low 310.62
50-day moving average 313.09
200-day moving average 314.46

Share statistics

Avg vol (3-month) 379.37k
Avg vol (10-day) 364.73k
Shares outstanding 533.76M
Implied shares outstanding 633.76M
Float 813.22M
% held by insiders 114.31%
% held by institutions 177.82%
Shares short (30 Apr 2024) 41.72M
Short ratio (30 Apr 2024) 422.71
Short % of float (30 Apr 2024) 48.74%
Short % of shares outstanding (30 Apr 2024) 45.11%
Shares short (prior month 28 Mar 2024) 41.77M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 14.42%
Operating margin (ttm)35.71%

Management effectiveness

Return on assets (ttm)3.01%
Return on equity (ttm)9.41%

Income statement

Revenue (ttm)162.87M
Revenue per share (ttm)4.89
Quarterly revenue growth (yoy)134.00%
Gross profit (ttm)N/A
EBITDA 26.96M
Net income avi to common (ttm)23.48M
Diluted EPS (ttm)0.69
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)327.41M
Total cash per share (mrq)10.31
Total debt (mrq)66.43M
Total debt/equity (mrq)24.66%
Current ratio (mrq)2.38
Book value per share (mrq)8.52

Cash flow statement

Operating cash flow (ttm)-89.11M
Levered free cash flow (ttm)-11.74M